Zielonka K, Izdebski B, Drozd-Sokolowska J, Pruszczyk-Matusiak K, et al. Venetoclax and obinutuzumab in first-line treatment of unfit patients with CLL - real-life data analysis of the Polish Adult leukemia group. Leuk Lymphoma 2025 Aug 1:1-9. doi: 10.1080/10428194.2025.2535693.
PMID: 40749704